Aminosteroid neuromuscular blocking drugs

Neostigmine. By far the most commonly used anticholinesterase in anaesthesia is neostigmine. This is a water-soluble quaternary ammonium compound that combines reversibly with the esteratic site of the acetylcholinesterase enzyme rendering it inactive for about 30 minutes. Neostigmine is given as an intravenous injection at a dose of mg/kg (maximum 5mg), and should be administered with glycopyrronium mg/kg or atropine mg/kg. Neostigmine starts to take effect after approximately 2 minutes but has its maximal effect at 5-7 minutes. It is excreted unchanged by the kidney and has a half-life of about 45 minutes.

Understanding & Establishing Intraosseous Access
Intraosseous (IO) access is an alternative method to providing venous administration of drugs and fluids. Commonly used by the military and pre-hospital medics, intraosseous access has expanded its use to a variety of settings: in the emergency department, at cardiac arrests, in the paediatric population, and is gaining popularity in adult settings where intravenous access is challenging or time critical.
Length of Study: 50 min
Difficulty:  Easy

On the other hand, we feel that endovascular therapies may be potentially more beneficial as a treatment option. Encouraging results have been reported with intra-arterial administration of papaverine and angioplasty of accessible spastic vessels. Timing of endovascular treatment is critically important to be effective. Intervention should be performed soon after it is apparent that a patient is progressing or failing to improve despite maximal medical therapy and before the onset of cerebral infarction. Indeed, cerebral angiography with the possibility of angiopalsty has become a routine part of our protocol in the management of symptomatic vasospasm. Figure 1 shows an example of a patient with symptomatic basilar artery vasospasm who made a significant recovery (from obtundation to following commands) after angioplasty.

Aminosteroid neuromuscular blocking drugs

aminosteroid neuromuscular blocking drugs


aminosteroid neuromuscular blocking drugsaminosteroid neuromuscular blocking drugsaminosteroid neuromuscular blocking drugsaminosteroid neuromuscular blocking drugsaminosteroid neuromuscular blocking drugs